BamSEC and AlphaSense Join Forces
Learn More

Predictive Oncology Inc. – Articles of Incorporation

NASDAQ: AGPU    
Share price (3/12/26): $1.78    
Market cap (3/12/26): $6.057 million

Articles of Incorporation Filter

EX-3.2
from 8-K 9 pages Article 2. Meetings of Stockholders
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Certificate of Incorporation of Predictive Oncology Inc. (A Delaware Corporation) [Signature Page Follows]
12/34/56
EX-3.1
from 8-K 1 page Amendment No. 1 to the Predictive Oncology Inc. 2024 Equity Inventive Plan
12/34/56
EX-3.1
from 8-K 1 page Amendment No. 2 to the Second Amended and Restated Bylaws of Predictive Oncology Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Certificate of Incorporation of Predictive Oncology Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Certificate of Incorporation of Predictive Oncology Inc
12/34/56
EX-3.1
from 8-A12G 6 pages Predictive Oncology Inc. Certificate of Designation of Series F Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.10
from S-1 13 pages Article 2. Meetings of Stockholders
12/34/56
EX-3.1
from 8-K 1 page Amendment to the Second Amended and Restated Bylaws of Predictive Oncology Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Certificate of Incorporation of Predictive Oncology Inc
12/34/56
EX-3.14
from 10-K 9 pages Precision Therapeutics Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Effective April 3, 2019
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Certificate of Incorporation of Predictive Oncology Inc
12/34/56
EX-3.1
from 8-K 8 pages Predictive Oncology Inc. Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Effective June 13, 2019
12/34/56
EX-3.2
from 8-K 13 pages Article 2. Meetings of Stockholders
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of the Certificate of Incorporation of Precision Therapeutics Inc
12/34/56
EX-3.2
from 8-K 2 pages First Amendment to Amended and Restated Bylaws of Precision Therapeutics Inc. (A Delaware Corporation) as of [ ], 2018
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment to the Certificate of Incorporation of Precision Therapeutics Inc. (A Delaware Corporation) Date: March 22, 2019
12/34/56
EX-3.2
from 8-K 12 pages Article 2. Meetings of Stockholders
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of the Certificate of Incorporation of Skyline Medical Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Certificate of Incorporation of Skyline Medical Inc
12/34/56